Eisuke Tsuda
25Patents
8h-index
44Co-inventors
75Inventor score
Filing activity: Mar 11, 1992 → Oct 11, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919434B1 | Monoclonal antibodies that bind OCIF | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5328836A | Plasmids containing DNA encoding the amino acid sequence of TCF-II and use thereof | Chemistry; Metallurgy | 26 | Expired |
| US6855808B2 | Proteins and methods for producing the proteins | Human Necessities | 15 | Expired |
| US8575316B2 | Anti-Siglec-15 antibody | Chemistry; Metallurgy | 15 | Active |
| US7125686B1 | Proteins and methods for producing the proteins | Human Necessities | 11 | Expired |
| US7276344B2 | Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein | Human Necessities | 10 | Expired |
| US7468268B2 | Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins | Human Necessities | 10 | Expired |
| US7205397B2 | Proteins and methods for producing the proteins | Human Necessities | 10 | Expired |
| US7449185B2 | Antibodies to OCIF-binding molecules | Physics | 8 | Expired |
| US7192718B2 | Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereof | Physics | 7 | Expired |
| US8546540B2 | Antibody targeting osteoclast-related protein Siglec-15 | Chemistry; Metallurgy | 7 | Active |
| US7527790B2 | Methods of reducing bone absorption comprising administering an antibody that binds OBM | Physics | 7 | Expired |
| US5648233A | Modified tumor cytotoxic factor (TCF) and DNA encoding such | Human Necessities | 7 | Expired |
| US9114131B2 | Antibody targeting osteoclast-related protein Siglec-15 | Chemistry; Metallurgy | 5 | Active |
| US6046033A | Basic osteoblast growth factor II (bOGF-II) | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6693175B2 | Method for diagnosing bone dysbolism | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9751944B2 | Anti-Siglec-15 antibody | Chemistry; Metallurgy | 3 | Active |
| US9815899B2 | Antibody targeting osteoclast-related protein siglec-15 | Chemistry; Metallurgy | 3 | Active |
| US9079959B2 | Methods of administering anti-Siglec-15 antibody | Chemistry; Metallurgy | 2 | Active |
| US9090692B2 | Antibody targeting osteoclast-related protein Siglec-15 | Chemistry; Metallurgy | 2 | Active |
| US6919312B2 | Bone-pathobolism treating agent | Human Necessities | 2 | Expired |
| US7252973B1 | Protein and processes for producing the same | Human Necessities | 1 | Expired |
| US10308715B2 | Antibody targeting osteoclast-related protein Siglec-15 | Chemistry; Metallurgy | 1 | Active |
| US10723800B2 | Antibody targeting osteoclast-related protein siglec-15 | Chemistry; Metallurgy | 0 | Active |
| US6998242B2 | Method of diagnosing metabolic bone diseases | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.